Supplemental Figure 1 from Early changes in circulating cell free KRAS G12C predicts response to adagrasib in KRAS mutant non-small cell lung cancer patients

Supplemental Figure 1: Quantitative concordance between NGS and ddPCR KRASG12C results. ctDNA, circulating tumor DNA; ddPCR, droplet digital polymerase chain reaction.